Moderate wine consumption has been linked to a lower risk of cardiovascular disease, according to a new study published in the European Heart Journal. The study, which analyzed data from over 7,500 participants in the PREDIMED trial, found that drinking 12-35 glasses of wine per month was associated with a reduced risk of heart failure, myocardial infarction, stroke, and cardiovascular death.
The researchers used urinary tartaric acid as a biomarker to measure wine consumption, which proved to be a reliable and accurate method. The study’s findings support previous research suggesting that moderate wine drinking has cardiovascular benefits.
The study’s authors found that the association between wine consumption and cardiovascular risk was strongest in people who drank 12-35 glasses of wine per month. This range of consumption was associated with a significant reduction in the risk of cardiovascular disease, compared to those who consumed fewer or more glasses of wine.
The researchers also found that changes in urinary tartaric acid levels over time were associated with an increased risk of cardiovascular disease. Participants who experienced an increase in their tartaric acid levels had a 59% lower risk of developing cardiovascular disease.
The study’s findings have implications for the understanding of the relationship between wine consumption and cardiovascular health. While the exact mechanisms behind this association are unclear, researchers believe that polyphenols may play a role. Polyphenols have been shown to have anti-inflammatory properties, which could contribute to their cardioprotective effects.
Overall, the study’s findings suggest that moderate wine consumption may be beneficial for cardiovascular health, and that urinary tartaric acid could be a useful biomarker for measuring this benefit.
Source: https://www.medpagetoday.com/cardiology/prevention/113456